Posts from the “!In/outputs” Category

IN/OUTPUTS Links re: Aaron Swartz

Posted on 13 January 2013

There’s a lot of beautiful and considered things being written about the loss of Aaron Swartz, so I thought I would pull together a bit of a list of the posts I particularly liked: Official statement from family and partner of Aaron Swartz The statement from Aaron’s family and his girlfriend is touching. On Remember Aaron Swartz, 12 January 2013. RIP, Aaron Swartz Cory Doctorow’s post on Boing Boing was the first post I read about Aaron’s death (I did have Quinn Norton’s post open, but I had only skimmed it). Cory offers a personal recount of Swartz. I love Cory’s colourful description of Aaron as “… a full-time, uncompromising, reckless and delightful shit-disturber” While Cory was developing Homeland, the sequel to Little Brother,…

Share Button

IN/OUTPUTS for 20 to 26 February

Posted on 20 February 2012

In/outputs - a taste plate of stuff that’s passed through my feeds this week 4921.0 – Participation in Selected Cultural Activities, Australia, 2010-11 The ABS has released a dataset and analysis of levels of participation in the arts by Australians over the age of 15 drawn from survey respondents to the 2010–11 Multipurpose Household Survey (MPHS). Turns out over that period 27% (4.7 million people) participated in a cultural activity of some kind (although less than half participated more than once). Of that amount, “Women had a higher participation rate in cultural activities (31%) than men (23%),” the ABS press release states, “but when it came to being paid, 18% of men received a wage, salary or other payment for their participation in cultural activities…

Share Button

IN/OUTPUTS for 13 to 19 February

Posted on 13 February 2012

In/outputs - a taste plate of stuff that’s passed through my feeds this week EU drive to protect drug firms puts fight against Aids at risk The European Union hopes to finalise a Free Trade Agreement with India at the 12th EU-India summit that will include a deal to slow production of low-price generic medicines for distribution to developing countries of India’s generic drug companies. While I can understand the economic incentive to control the development of generics by Western pharmaceuticals, there’s a human cost that is more important. Just look at generic HIV anti-viral medication for example: as the The Independent reports, “More than 80 per cent of those on HIV treatment in developing countries are on generic medicines made in India.” I hope…

Share Button